Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Clinical Trial Supplies Market, by Region, 2020-2028 (USD Billion)
1.2.2. Clinical Trial Supplies Market, by Service, 2020-2028 (USD Billion)
1.2.3. Clinical Trial Supplies Market, by End-Use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Clinical Trial Supplies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Clinical Trial Supplies Market Dynamics
3.1. Clinical Trial Supplies Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing R&D expenditure of pharmaceutical and biopharmaceutical companies
3.1.1.2. Increasing number of registered clinical trials
3.1.2. Market challenges
3.1.2.1. High cost of drug development
3.1.3. Market opportunities
3.1.3.1. Increasing emerging markets
Chapter 4. Global Clinical Trial Supplies Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Clinical Trial Supplies Market, by Service
6.1. Market Snapshot
6.2. Global Clinical Trial Supplies Market by Service, Performance - Potential Analysis
6.3. Global Clinical Trial Supplies Market Estimates & Forecasts by Service, 2019-2028 (USD Billion)
6.4. Clinical Trial Supplies Market, Sub Segment Analysis
6.4.1. Logistics & distribution
6.4.2. Storage & retention
6.4.3. Packaging, labeling, and blinding
6.4.4. Manufacturing
6.4.5. Comparator sourcing
6.4.6. Other services
Chapter 7. Global Clinical Trial Supplies Market, by End-Use
7.1. Market Snapshot
7.2. Global Clinical Trial Supplies Market by End-Use, Performance - Potential Analysis
7.3. Global Clinical Trial Supplies Market Estimates & Forecasts by End-Use, 2019-2028 (USD Billion)
7.4. Clinical Trial Supplies Market, Sub Segment Analysis
7.4.1. Pharmaceutical & Biotechnology companies
7.4.2. Contract Research Organisations (CROs)
7.4.3. Medical Devices Companies
Chapter 8. Global Clinical Trial Supplies Market, Regional Analysis
8.1. Clinical Trial Supplies Market, Regional Market Snapshot
8.2. North America Clinical Trial Supplies Market
8.2.1. U.S. Clinical Trial Supplies Market
8.2.1.1. Service breakdown estimates & forecasts, 2019-2028
8.2.1.2. End-Use breakdown estimates & forecasts, 2019-2028
8.2.2. Canada Clinical Trial Supplies Market
8.3. Europe Clinical Trial Supplies Market Snapshot
8.3.1. U.K. Clinical Trial Supplies Market
8.3.2. Germany Clinical Trial Supplies Market
8.3.3. France Clinical Trial Supplies Market
8.3.4. Spain Clinical Trial Supplies Market
8.3.5. Italy Clinical Trial Supplies Market
8.3.6. Rest of Europe Clinical Trial Supplies Market
8.4. Asia-Pacific Clinical Trial Supplies Market Snapshot
8.4.1. China Clinical Trial Supplies Market
8.4.2. India Clinical Trial Supplies Market
8.4.3. Japan Clinical Trial Supplies Market
8.4.4. Australia Clinical Trial Supplies Market
8.4.5. South Korea Clinical Trial Supplies Market
8.4.6. Rest of Asia Pacific Clinical Trial Supplies Market
8.5. Latin America Clinical Trial Supplies Market Snapshot
8.5.1. Brazil Clinical Trial Supplies Market
8.5.2. Mexico Clinical Trial Supplies Market
8.6. Rest of The World Clinical Trial Supplies Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Biocair (UK)
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Thermo Fisher (US)
9.2.3. Catalent, Inc. (US)
9.2.4. Parexel (US)
9.2.5. Eurofins (France)
9.2.6. UDG Healthcare (Ireland)
9.2.7. Piramal Pharma Solutions (India)
9.2.8. Almac Group (UK)
9.2.9. PCI Pharma Services (US)
9.2.10. PRA Health Sciences (US)
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption